Submissions for the 2023 Health Equity FlexGrant will be accepted until Friday, February 10, 2023
Announcing a limited grant opportunity to support pediatric medical device innovators who are focused on addressing health inequities in pediatrics through their technology. The CDC defines Health Equity as a person’s “opportunity to attain his or her full health potential, and no one is disadvantaged from achieving this potential because of social position or other socially determined circumstances."
The proposed solution can focus on any factor that impacts health equity, including but not limited to:
Companies will be awarded grants up to $15,000 to support activities that apply or adapt their existing medical device to help address health inequities in children. Medical devices with adult indications that are expanding or wish to expand their clinical indication to pediatrics are welcome to apply.
You will need to attach a company executive summary (max 2 pages) and/or pitch deck (max 25 slides) and a proposal of how you will utilize your medical device to help address health inequity(ies) in children.
All companies must meet CTIP's minimum criteria to receive support:
In addition to the minimum criteria noted above, all companies must also:
Funds may be used for the following:
Funds may not be used for:
Proposals will be evaluated on the following criteria:
To help you put together your proposal, we have curated some resources listed below.
This is a grant, not a loan or investment for equity. CTIP acknowledges that the submission of this application does not grant CTIP any rights to the work and any accompanying intellectual property is owned by the submitter. All rights to inventions, whether patentable or not, conceived or first actually reduced to practice by one or more applicants will belong to the submitter. Inventorship is decided between and among the team members involved with a given invention. Team members agree to negotiate in good faith the disposition of joint invention. The submitter acknowledges that material submitted for review by CTIP for which the submitter requests support is their own work or is submitted with permission from the entity that has legal rights to the material. CTIP may use the submitter‘s name, the submitter‘s institution, the project name the project description and associated brand assets for, including but not limited to, CTIP‘s internal tracking, record keeping, branding, website, press releases and social media presence, as well as to comply with reporting requirements mandated by the FDA (as part of our contractual obligation).